Showing results (491-500 of 646) with videos related to

Sort By:
Pageof 65
Medrxiv : the Preprint Server for Health Sciences|September 25, 2023
Glycemic outcomes of a family-focused intervention for adults with type 2 diabetes: Main, mediated, and subgroup effects from the FAMS 2.0 RCTLyndsay A Nelson, Andrew J Spieker, Robert A Greevy, et al.
Medrxiv : the Preprint Server for Health Sciences|September 25, 2023
Well-being outcomes of a family-focused intervention for persons with type 2 diabetes and support persons: Main, mediated, and subgroup effects from the FAMS 2.0 RCTMcKenzie K Roddy, Andrew J Spieker, Lyndsay A Nelson, et al.
ESC Heart Failure|September 7, 2021
Human myocardial mitochondrial oxidative capacity is impaired in mild acute heart transplant rejectionDaniel Scheiber, Elric Zweck, Sophie Albermann, et al.
Diabetes Research and Clinical Practice|November 4, 2023
Glycemic outcomes of a family-focused intervention for adults with type 2 diabetes: Main, mediated, and subgroup effects from the FAMS 2.0 RCTLyndsay A Nelson, Andrew J Spieker, Robert A Greevy, et al.
Hospital Pediatrics|May 2, 2024
Evaluating Acute Viral Gastroenteritis Severity: Modified Vesikari and Clark Scoring SystemsCarlos Plancarte, Tess Stopczynski, Lubna Hamdan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 8, 2020
Epidemiological Trends of Racial Differences in Early- and Late-onset Group B Streptococcus Disease in TennesseeLubna Hamdan, Simon Vandekar, Andrew J Spieker, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 4, 2014
Immune suppression via glucocorticoid-stimulated monocytes: a novel mechanism to cope with inflammationGeorg Varga, Jan Ehrchen, Anne Brockhausen, et al.
Lung Cancer (Amsterdam, Netherlands)|January 19, 2016
Blood group antigen A type 3 expression is a favorable prognostic factor in advanced NSCLCL H Schmidt, A Kuemmel, C Schliemann, et al.
Pageof 65